Mckesson Has 'OneStop' Generics Plan

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p71
Trade Publication
The article reports on the OneStop Generics program at McKesson Pharmaceuticals which provides auto-shipment programs which deliver blockbuster generics to its pharmacy customers within 48 hours to provide them with immediate supply to begin dispensing to their patients in the U.S.


Related Articles

  • Generic surge is predicted.  // DCI;Jan1995, Vol. 156 Issue 1, p6 

    Reports on Frost & Sullivan Inc.'s prediction of a doubling of the generic drug business by the year 2000 due a continuing high rate of loss of patent protection for major drugs. $5.89 billion generic sales forecast by 2000; Strong flood of new gastrointestinal drugs; Other factors for surge...

  • PBM shares strategy behind Prozac switch success.  // Formulary;Nov2001, Vol. 36 Issue 11, p778 

    Reports on the launch of a generic fluoxetine by MerckMedco in the United States. Formula for the generic-switching; Awareness of doctors on the generic; Education of prescribers by pharmacists.

  • No user fees on generics now.  // Drug Topics;7/7/97, Vol. 141 Issue 13, p8 

    States that a proposal has been made to charge generic drugmakers user fees to get their applications processed quicker by the Food and Drug Administration. Financial information on the fees; Name of the representative who made the suggestion.

  • Substandard drugs marketed in Africa.  // Reactions Weekly;Oct2014, Vol. 1522 Issue 1, p14 

    The article reports that according to the authors of a working paper, substandard generic drugs which claim to be manufactured in India are being marketed in Africa.

  • Quality/service, not price, called key to generics. Muirhead, Greg // Drug Topics;8/8/94, Vol. 138 Issue 15, p44 

    Presents guidelines for generic drug manufacturers to stay competitive. Marketing strategies used by Stuart Schansinger of E. Fougera & Co.; E. Fougera's company operations; Establishing a high-quality image; Developing strong alliances with distributors and buying groups; Expanding beyond...

  • The growth surge continues. Rankin, Ken // Drug Store News;7/08/96, Vol. 18 Issue 10, p20 

    Examines the status of the generic drug market in the United States. Greater willingness among physicians to prescribe drugs generically; Tendency of pharmacists to substitute generics for brand name products; Patent expirations affecting a series of top-selling brand name drugs.

  • Spate of New Generic Versions Enter Marketplace.  // Chain Drug Review;7/18/2011, Vol. 33 Issue 12, p97 

    The article reports on the launch of generic drugs in the U.S. which include the Levofloxacin antibiotic drug by Wockhardt USA LLC, Donapezil Alzheimer's disease drug by Dr. Reddy's Laboratories Ltd., and the Syeda contraceptive drug by Sandoz Inc.

  • Industry advocates tout increase in generics use. DeArment, Alaric // Drug Store News;2/28/2011, Vol. 33 Issue 3, p32 

    The article reports on the increased usage of generic drug in 2011 in the U.S.

  • Generic drugs make global strides. DEARMENT, ALARIC // Drug Store News;9/16/2013, Vol. 35 Issue 9, p24 

    The article reports on the growth of generic drugs manufacturing in the international market.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics